Analyst Ratings for Alterity Therapeutics (ATHE)
Avg. $ Target:
N/A
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/16/2026 | Ladenburg Thalmann | N/A | New Coverage | Buy (N/A) |
N/A (N/A) |
4.41 (4.88) |
10.66% | Details |
| 2/3/2025 | Benchmark | Bob Wasserman | New Coverage | Speculative Buy (N/A) |
N/A (N/A) |
4.80 (4.88) |
1.67% | Details |
 |
||||||||
